نتایج جستجو برای: CRISPR/Cas

تعداد نتایج: 7  

Journal: :Nature biotechnology 2013
Qiwei Shan Yanpeng Wang Jun Li Yi Zhang Kunling Chen Zhen Liang Kang Zhang Jinxing Liu Jianzhong Jeff Xi Jin-Long Qiu Caixia Gao

1. Jinek, M. et al. Science 337, 816–821 (2012). 2. Cho, S.W., Kim, S., Kim, J.M. & Kim, J.S. Nat. Biotechnol. 31, 230–232 (2013). 3. Cong, L. et al. Science 339, 819–823 (2013). 4. Mali, P. et al. Science 339, 823–826 (2013). 5. Hwang, W.Y. et al. Nat. Biotechnol. 31, 227–229 (2013). 6. Jiang, W., Bikard, D., Cox, D., Zhang, F. & Marraffini, L.A. Nat. Biotechnol. 31, 233–239 (2013). 7. Wang, H...

2016
Ge Dong Mingxiong He Hong Feng

CRISPR-Cas (clustered regularly interspaced short palindromic repeats—CRISPR associated proteins) is a RNA-guided defense immune system that prevents some genetic elements such as plasmids and virus from getting into the bacterial cells. Zymomonas mobilis is an ethanologenic bacterium, which encodes a subtype I-F CRISPR-Cas system containing three CRISPR loci and a far distant cas gene cluster....

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2013
Ryan M Walsh Konrad Hochedlinger

Targeted genome engineering has been instrumental for the study of biological processes, and it holds great promise for the treatment of disease. Historically, gene targeting by homologous recombination has been the preferred method to modify specific genes in mouse and human cells (Fig. 1). However, this approach is hampered by low efficiency, the requirement for drug selection to detect targe...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2015
Keith T Gagnon David R Corey

Most new technologies for manipulating gene expression in mammalian cells are accepted at a relatively slow pace. Occasionally, however, a new technology is so robust and fills such a critical niche that its adoption is widespread and rapid. Fifteen years ago, duplex RNAs were such a technology. RNA interference (RNAi) in mammalian cells was first demonstrated in 2001 (1) and within 2 y RNAi wa...

2015
Monika Glemzaite Egle Balciunaite Tautvydas Karvelis Giedrius Gasiunas Mantvyda M Grusyte Gediminas Alzbutas Aiste Jurcyte Emily M Anderson Elena Maksimova Anja J Smith Arvydas Lubys Lolita Zaliauskiene Virginijus Siksnys

Cas9 protein of the Type II CRISPRCas (Clustered Regularly Interspaced Short Palindromic Repeats-CRISPR associated) bacterial adaptive immune system emerged recently as a promising tool for genome editing in human and other eukaryotic cells. Cas9 binds a dual crRNA (CRISPR RNA)-tracrRNA (transactivating RNA) molecule, or an artificial single-guide RNA (sgRNA) into a functional complex that acts...

2015
John van der Oost

The struggle for life has been the main driving force in natural evolution. Billions of years of competition and warfare between viruses, prokaryotes and eukaryotes (in any combination) have shaped the present world. Among these violent encounters, the attack of bacteria by viruses is probably the most frequently occurring host–parasite interaction on our planet. The offensive bacteriophages ar...

2014
Lisa-Katharina Maier Aris-Edda Stachler Sita J. Saunders Rolf Backofen Anita Marchfelder

The prokaryotic immune system CRISPRCas is a defence system that protects prokaryotes against foreign DNA. The short CRISPR RNAs (crRNAs) are central components of this immune system. In CRISPR-Cas systems type I and III crRNAs are generated by the endonuclease Cas6. We developed a Cas6b-independent crRNA maturation pathway for the Haloferax type I-B system in vivo, that expresses a functional ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید